Arca Biopharma reported $-5676000 in Net Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 1317M 159M
Arca Biopharma ABIO:US $ -5.68M 1.58M
Biogen BIIB:US $ 1058M 754.2M
Brainstorm Cell Therapeutics BCLI:US $ -5.36M 0.83M
Bristol Myers Squibb BMY:US $ 1421M 143M
Cytokinetics CYTK:US $ -19.82M 69.62M
Cytrx CYTR:US -1295910 7.73M
Daiichi Sankyo 4568:JP Y 18852M 46197M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Laboratory Of America LH:US $ 358.6M 133M
Otsuka Holdings 4578:JP Y 46497M 23240M
Pfizer PFE:US $ 9905M 2042M
United Therapeutics UTHR:US $ 116M 123.9M